These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage. Welsh A; McLintock C; Gatt S; Somerset D; Popham P; Ogle R Aust N Z J Obstet Gynaecol; 2008 Feb; 48(1):12-6. PubMed ID: 18275566 [TBL] [Abstract][Full Text] [Related]
5. Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry. Phillips LE; McLintock C; Pollock W; Gatt S; Popham P; Jankelowitz G; Ogle R; Cameron PA; Anesth Analg; 2009 Dec; 109(6):1908-15. PubMed ID: 19923520 [TBL] [Abstract][Full Text] [Related]
6. The use of recombinant activated FVII in postpartum hemorrhage. Franchini M; Franchi M; Bergamini V; Montagnana M; Salvagno GL; Targher G; Lippi G Clin Obstet Gynecol; 2010 Mar; 53(1):219-27. PubMed ID: 20142658 [TBL] [Abstract][Full Text] [Related]
7. Recombinant activated factor VII (rFVIIa/NovoSeven®) in the management of severe postpartum haemorrhage: initial report of a multicentre case series in Japan. Kobayashi T; Nakabayashi M; Yoshioka A; Maeda M; Ikenoue T Int J Hematol; 2012 Jan; 95(1):57-63. PubMed ID: 22160834 [TBL] [Abstract][Full Text] [Related]
8. [Recombinant activated factor VII as a life-saving therapy for severe postpartum haemorrhage unresponsive to conservative traditional management]. Brice A; Hilbert U; Roger-Christoph S; Fernandez H; Dumenil AS; Descorps-Declère A; Mercier F; Benhamou D Ann Fr Anesth Reanim; 2004 Nov; 23(11):1084-8. PubMed ID: 15581725 [TBL] [Abstract][Full Text] [Related]
9. Recombinant human factor VIIa prevents hysterectomy in severe postpartum hemorrhage: single center study. Huber AW; Raio L; Alberio L; Ghezzi F; Surbek DV J Perinat Med; 2011 Oct; 40(1):43-9. PubMed ID: 22017328 [TBL] [Abstract][Full Text] [Related]
11. Successful management by recombinant activated factor VII in a case of disseminated intravascular coagulopathy caused by obstetric hemorrhage. Nohira T; Osakabe Y; Suda S; Takahashi C; Tanaka A; Ikeda K; Ikeda T; Okabe K J Obstet Gynaecol Res; 2008 Aug; 34(4 Pt 2):623-30. PubMed ID: 18840167 [TBL] [Abstract][Full Text] [Related]
12. Massive postpartum hemorrhage: recombinant factor VIIa use is safe but not effective. Kalina M; Tinkoff G; Fulda G Del Med J; 2011 Apr; 83(4):109-13. PubMed ID: 21675158 [TBL] [Abstract][Full Text] [Related]
13. Use of recombinant activated factor VII in severe post-partum haemorrhage: data from the Italian Registry: a multicentric observational retrospective study. Barillari G; Frigo MG; Casarotto M; Farnia A; Massè B; Wetzl R; Bianchin A; Rabi A; Malacarne P; Pasca S; Bigotto E; Thromb Res; 2009 Dec; 124(6):e41-7. PubMed ID: 19783283 [TBL] [Abstract][Full Text] [Related]
14. Recombinant factor VIIa for life-threatening post-partum haemorrhage. Ahonen J; Jokela R Br J Anaesth; 2005 May; 94(5):592-5. PubMed ID: 15708871 [TBL] [Abstract][Full Text] [Related]
15. Experience with recombinant activated factor VII for severe post-partum hemorrhage in Japan, investigated by Perinatology Committee, Japan Society of Obstetrics and Gynecology. Murakami M; Kobayashi T; Kubo T; Hata T; Takeda S; Masuzaki H J Obstet Gynaecol Res; 2015 Aug; 41(8):1161-8. PubMed ID: 26013425 [TBL] [Abstract][Full Text] [Related]
16. Use of recombinant factor VIIa in massive post-partum haemorrhage. McMorrow RC; Ryan SM; Blunnie WP; Bowen M; Carton EG; Gardiner J; Geary M; Loughrey JP Eur J Anaesthesiol; 2008 Apr; 25(4):293-8. PubMed ID: 18177539 [TBL] [Abstract][Full Text] [Related]
17. Use of recombinant activated factor VII in a case of severe postpartum haemorrhage. Verre M; Bossio F; Mammone A; Piccirillo M; Tancioni F; Varano M Minerva Ginecol; 2006 Feb; 58(1):81-4. PubMed ID: 16498374 [TBL] [Abstract][Full Text] [Related]
18. The role of recombinant activated Factor VII in major obstetric haemorrhage: the Farnborough experience. Wissa I; Ebeid E; El-Shawarby S; Chandakas S; Kamal T; Hill N J Obstet Gynaecol; 2009 Jan; 29(1):21-4. PubMed ID: 19280490 [TBL] [Abstract][Full Text] [Related]
19. Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000-2004. Alfirevic Z; Elbourne D; Pavord S; Bolte A; Van Geijn H; Mercier F; Ahonen J; Bremme K; Bødker B; Magnúsdóttir EM; Salvesen K; Prendiville W; Truesdale A; Clemens F; Piercy D; Gyte G Obstet Gynecol; 2007 Dec; 110(6):1270-8. PubMed ID: 18055720 [TBL] [Abstract][Full Text] [Related]
20. [Recombinant activated factor VII in the treatment of life threatening post-partum haemorrhage; registry UniSeven in the Czech Republic]. Seidlová D; Blatný J; Penka M; Ovesná P; Brabec P; Sevcík P; Ventruba P; Cerný V Ceska Gynekol; 2010 Aug; 75(4):297-305. PubMed ID: 20925226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]